» Articles » PMID: 33091507

Copper Metabolism As a Unique Vulnerability in Cancer

Overview
Publisher Elsevier
Date 2020 Oct 22
PMID 33091507
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

The last 25 years have witnessed tremendous progress in identifying and characterizing proteins that regulate the uptake, intracellular trafficking and export of copper. Although dietary copper is required in trace amounts, sufficient quantities of this metal are needed to sustain growth and development in humans and other mammals. However, copper is also a rate-limiting nutrient for the growth and proliferation of cancer cells. Oral copper chelators taken with food have been shown to confer anti-neoplastic and anti-metastatic benefits in animals and humans. Recent studies have begun to identify specific roles for copper in pathways of oncogenic signaling and resistance to anti-neoplastic drugs. Here, we review the general mechanisms of cellular copper homeostasis and discuss roles of copper in cancer progression, highlighting metabolic vulnerabilities that may be targetable in the development of anticancer therapies.

Citing Articles

Evaluation of Mortality Risk Factors in Prostate Cancer: Impact of Demographic, Clinical, Laboratory, Therapeutic, and Trace Element Influences.

Mbey P, Diangienda P, Mukuku O, Arung W, Banza C, Mafuta A Cancer Rep (Hoboken). 2025; 8(3):e70166.

PMID: 40067073 PMC: 11894822. DOI: 10.1002/cnr2.70166.


CDKN2A, a key gene in copper-induced cell death model, influencing melanoma invasion and apoptosis.

Li J, Yang X, Yin C, Li S, Xu Y, Liu B Discov Oncol. 2025; 16(1):246.

PMID: 40014167 PMC: 11867994. DOI: 10.1007/s12672-025-01992-8.


Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.

Imam M, Ji J, Zhang Z, Yan S Front Pharmacol. 2025; 15:1493188.

PMID: 39867656 PMC: 11757020. DOI: 10.3389/fphar.2024.1493188.


Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications.

Cong Y, Li N, Zhang Z, Shang Y, Zhao H J Transl Med. 2025; 23(1):104.

PMID: 39844182 PMC: 11752808. DOI: 10.1186/s12967-025-06121-1.


Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma.

Huang Y, Luo G, Sheng X, Li J Sci Rep. 2025; 15(1):2210.

PMID: 39825108 PMC: 11742449. DOI: 10.1038/s41598-025-86756-8.


References
1.
Xu J, Brosseau J, Shi H . Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy. Oncogene. 2020; 39(48):7106-7113. DOI: 10.1038/s41388-020-01491-w. View

2.
Kagan H, Li W . Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003; 88(4):660-72. DOI: 10.1002/jcb.10413. View

3.
Safaei R, Otani S, Larson B, Rasmussen M, Howell S . Transport of cisplatin by the copper efflux transporter ATP7B. Mol Pharmacol. 2007; 73(2):461-8. DOI: 10.1124/mol.107.040980. View

4.
Ishida S, Lee J, Thiele D, Herskowitz I . Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci U S A. 2002; 99(22):14298-302. PMC: 137878. DOI: 10.1073/pnas.162491399. View

5.
Blockhuys S, Zhang X, Wittung-Stafshede P . Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration. Proc Natl Acad Sci U S A. 2020; 117(4):2014-2019. PMC: 6995000. DOI: 10.1073/pnas.1910722117. View